NFκB-dependent signaling pathways

Experimental Hematology

Volumn 30, Issue 4, 2002, Pages 285-296

  Li, Xiaoxia ^a   Stark, George R ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

CANCER; CELL DEATH; CELL MATURATION; CELL PROTECTION; CELL SURVIVAL; DEVELOPMENT; ENZYME ACTIVATION; HUMAN; IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PHYSICAL STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; CELL FUNCTION; IMMUNOLOGY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; STRESS;

ANIMALS; CELL PHYSIOLOGY; HUMANS; IMMUNITY; NF-KAPPA B; SIGNAL TRANSDUCTION; STRESS;

EID: 0036009909     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00777-4     Document Type: Review

References (161)

1. Multiple nuclear factors interact with the immunoglobulin enhancer sequences
2. Phylogenetic perspectives in innate immunity
3. Function and activation of NF-κ B in the immune system
4. Structure, regulation and function of NF-κ B
5. Phosphorylation meets ubiquitination: The control of NF-κB activity
6. ATP-dependent proteases degrade their substrates by processively unraveling them from the degradation signal
7. A glycine-rich region in NF-κB p105 functions as a processing signal for the generation of the p50 subunit
8. Structural motifs involved in ubiquitin-mediated processing of the NF-κB precursor p105: Roles of the glycine-rich region and a downstream ubiquitination domain
9. Role of the ubiquitin-proteasome pathway in NF-κB activation
10. Cotranslational biogenesis of NF-κB p50 by the 26S proteasome
11. Cotranslational dimerization of the Rel homology domain of NF-κB1 generates p50-p105 heterodimers and is required for effective p50 production
12. Nf-κ B: Ten years after
13. Crystal structure of p50/p65 heterodimer of transcription factor NF-κB bound to DNA
14. Structure of the human NF-κB p52 homodimer-DNA complex at 2.1 A resolution
15. Structure of NF-κ B p50 homodimer bound to a κ B site
16. NF-κ B and Rel proteins: Evolutionarily conserved mediators of immune responses
17. Nedd8 modification of cul-1 activates SCF(β(TrCP))-dependent ubiquitination of IκBα
18. NF-κB signaling pathways in mammalian and insect innate immunity
19. The transcriptional activity of NF-κB is regulated by the IκB-associated PKAc subunit through a cyclic AMP-independent mechanism
20. Phosphorylation of NF-κ B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300
21. Activation of nuclear factor-κB-dependent transcription by tumor necrosis factor-α is mediated through phosphorylation of RelA/p65 on serine 529
22. Tumor necrosis factor α-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II
23. Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-κB p65/RelA subunit
24. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB
25. Akt stimulates the transactivation potential of the RelA/p65 subunit of NF-κ B through utilization of the Iκ B kinase and activation of the mitogen-activated protein kinase p38
26. Activators and target genes of Rel/NF-κB transcription factors
27. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
28. IKK-1 and IKK-2: Cytokine-activated IκB kinases essential for NF-κB activation
29. Identification and characterization of an IκB kinase
30. IκB kinase-β: NF-κB activation and complex formation with IκB kinase-α and NIK
31. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB; activation
32. Complementation cloning of NEMO, a component of the IκB kinase complex essential for NF-κB activation
33. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-κ B activation
34. Defective lymphotoxin-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice
35. Essential role of nuclear factor (NF)-κB-inducing kinase and inhibitor of κB (IκB) kinase α in NF-κB activation through lymphotoxin β receptor, but not through tumor necrosis factor receptor I
36. NF-κB-inducing kinase regulates the processing of NF-κB2 p100
37. The essential role of MEKK3 in TNF-induced NF-κB activation
38. Severe liver degeneration in mice lacking the IκB kinase 2 gene
39. The IKKβ subunit of IκB kinase (IKK) is essential for nuclear factor κB activation and prevention of apoptosis
40. Embryonic lethality, liver degeneration, and impaired NF-κ B activation in IKK-β-deficient mice
41. Complete lack of NF-κB activity in IKK1 and IKK2 double-deficient mice: Additional defect in neurulation
42. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKα subunit of IκB kinase
43. IKK1-deficient mice exhibit abnormal development of skin and skeleton
44. Limb and skin abnormalities in mice lacking IKKα
45. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice
46. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti
47. Female mice heterozygous for IKK γ/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti
48. NEMO/IKK γ-deficient mice model incontinentia pigmenti
49. A new family of IKK-related kinases may function as I κ B kinase kinases
50. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases
51. NF-κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase
52. NAK is an IκB kinase-activating kinase
53. NF-κB activation through IKK-I-dependent I-TRAF/TANK phosphorylation
54. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-κB-dependent gene transcription
55. Tumor suppressor MMAC/PTEN inhibits cytokine-induced NFκB activation without interfering with the IκB degradation pathway
56. Distinct roles of the IκB kinase α and β subunits in liberating nuclear factor κB (NF-κB) from IκB and in phosphorylating the p65 subunit of NF-κB
57. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
58. A family of human receptors structurally related to Drosophila Toll
59. TLR6: A novel member of an expanding toll-like receptor family
60. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9
61. A Toll-like receptor recognizes bacterial DNA
62. Two TNF receptors
63. The TNF receptor 1-associated protein TRADD signals cell death and NF-κ B activation
64. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
65. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex
66. RIP2 is a novel NF-κB-activating and cell death-inducing kinase
67. RIP3, a novel apoptosis-inducing kinase
68. Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex
69. Recruitment of IRAK to the interleukin 1 receptor complex requires interleukin 1 receptor accessory protein
70. A critical role for interleukin-1 receptor accessory protein in interleukin-1 signaling
71. The interleukin-1 receptor accessory protein (IL-1RAcP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases)
72. Nucleotide sequence and expression of a cDNA encoding MyD88, a novel myeloid differentiation primary response gene induced by IL-6
73. MyD88: An adapter that recruits IRAK to the IL-1 receptor complex
74. Irak: A kinase associated with the interleukin-1 receptor
75. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor
76. TRAF6 is a signal transducer for interleukin-1
77. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling
78. IRAK-M is a novel member of the Pelle/interleukin-1 receptor-associated kinase (IRAK) family
79. Tumor necrosis factor receptor-associated factors (TRAFs) - A family of adapter proteins that regulates life and death
80. TAK1 mitogen-activated protein kinase kinase kinase is activated by autophosphorylation within its activation loop
81. The kinase TAK1 can activate the NIK-I κB as well as the MAP kinase cascade in the IL-1 signalling pathway
82. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages
83. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway
84. Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway
85. IRAK-mediated translocation of TRAF6 and TAB2 in the interleukin-1-induced activation of NFκ B
86. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain
87. TAK1 is a ubiquitin-dependent kinase of MKK and IKK
88. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages
89. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide
90. The atypical PKC-interacting protein p62 channels NF-κB activation by the IL-1-TRAF6 pathway
91. The interleukin-1 receptor/Toll-like receptor superfamily: Signal generators for pro-inflammatory interleukins and microbial products
92. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene
93. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components
94. Cutting edge: Preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway
95. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
96. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
97. Cloning and characterization of the murine toll-like receptor 5 (Tlr5) gene: Sequence and mRNA expression studies in Salmonella-susceptible MOLF/Ei mice
98. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
99. Identification and characterization of SIGIRR, a molecule representing a novel subtype of the IL-1R superfamily
100. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function
101. Unresponsiveness of MyD88-deficient mice to endotoxin
102. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction
103. TIRAP: An adapter molecule in the toll signaling pathway
104. The TNF and TNF receptor superfamilies: Integrating mammalian biology
105. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction
106. Human Nod1 confers responsiveness to bacterial lipopolysaccharides
107. CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri
108. Autoimmunity and apoptosis: The Crohn’s connection
109. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease
110. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease
111. Protein oxidation in aging, disease, and oxidative stress
112. Antioxidant and redox regulation of gene transcription
113. Is NF-κB the sensor of oxidative stress?
114. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κ B transcription factor and HIV-1
115. Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-κB and activated protein-1
116. 2 and antioxidants have opposite effects on activation of NF-κ B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor
117. Separation of oxidant-initiated and redox-regulated steps in the NF-κ B signal transduction pathway
118. Amino acid analogs activate NF-κB through redox-dependent IκB-α degradation by the proteasome without apparent IκB-α phosphorylation. Consequence on HIV-1 long terminal repeat activation
119. Inhibition of I κ B-α phosphorylation and degradation and subsequent NF-κ B activation by glutathione peroxidase overexpression
120. Ionizing radiation and short wavelength UV activate NF-κB through two distinct mechanisms
121. Sequential DNA damage-independent and -dependent activation of NF-κB by UV
122. Tyrosine phosphorylation of I κ B-α activates NF-κ B without proteolytic degradation of I κ B-α
123. Site-specific tyrosine phosphorylation of IκBα negatively regulates its inducible phosphorylation and degradation
124. Rel/NF-κ B transcription factors and the control of apoptosis
125. Inhibition of c-myc expression induces apoptosis of WEHI 231 murine B cells
126. Inhibition of NF-κB/Rel induces apoptosis of murine B cells
127. Role of Rel-related factors in control of c-myc gene transcription in receptor-mediated apoptosis of the murine B cell WEHI 231 line
128. TGF β 1 inhibits NF-κ B/Rel activity inducing apoptosis of B cells: Transcriptional activation of I κ B α
129. The adaptor protein BLNK is required for B cell antigen receptor-induced activation of nuclear factor-κ B and cell cycle entry and survival of B lymphocytes
130. Bruton’s tyrosine kinase is required for activation of IκB kinase and nuclear factor κB in response to B cell receptor engagement
131. Phospholipase C-γ 2 couples Bruton’s tyrosine kinase to the NF-κB signaling pathway in B lymphocytes
132. Abnormal development and function of B lymphocytes in mice deficient for the signaling adaptor protein SLP-65
133. Requirement for B cell linker protein (BLNK) in B cell development
134. The B cell-restricted adaptor BASH is required for normal development and antigen receptor-mediated activation of B cells
135. Defective B cell development and function in Btk-deficient mice
136. Impaired expansion of mouse B cell progenitors lacking Btk
137. Phospholipase Cγ2 is essential in the functions of B cell and several Fc receptors
138. bcl-10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure
139. bcl-10 and MALT1, independent targets of chromosomal translocation in malt lymphoma, cooperate in a novel NF-κ B signaling pathway
140. Regulatory mechanisms of TRAF2-mediated signal transduction by bcl-10, a MALT lymphoma-associated protein
141. Constitutive pre-TCR signaling promotes differentiation through Ca2+ mobilization and activation of NF-κB and NFAT
142. NF-κ B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development
143. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
144. The TNF receptor 1-associated protein TRADD signals cell death and NF-κ B activation
145. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways
146. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis
147. FADD/MORT1 is a common mediator of CD95 (Fas/APO-1) and tumor necrosis factor receptor-induced apoptosis
148. A novel domain within the 55 kd TNF receptor signals cell death
149. A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen
150. CD30/TNF receptor-associated factor interaction: NF-κ B activation and binding specificity
151. Discrete signaling regions in the lymphotoxin-β receptor for tumor necrosis factor receptor-associated factor binding, subcellular localization, and activation of cell death and NF-κB pathways
152. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2
153. TNF- and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-κB
154. NF-κB signals induce the expression of c-FLIP
155. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
156. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
157. Aberrant rel/nfkb genes and activity in human cancer
158. Activators and target genes of Rel/NF-κB transcription factors
159. Negative regulation of transactivation function but not DNA binding of NF-κB and AP-1 by IκBβ1 in breast cancer cells
160. Genetic approaches in mice to understand Rel/NF-κB and IκB function: Transgenics and knockouts
161. Requirement for NF-κB in osteoclast and B-cell development